// App-Quantinova.ai

: Estimating the Effect of Individual Agents in the Treatment of Relapsed, Refractory Multiple Myeloma (RRMM)

Researchers

Presenter

  • Neil Hawkins

Principal Investigators

  • Karthik Ramasamy

  • Sujith Dhanasiri

Medical Centers

  • University of Glasgow, Glasgow, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Celgene International Sarl, Boudry, Switzerland

Locations

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved